CD24, formerly known as glycosylated mucin‐like cell surface protein, is a newly identified antiphagocytic molecule that can be harnessed by cancer cells to avoid attack from Siglec‐10‐expressing macrophages [11]. The gene discussed is CD24; the disease is cancer.